<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01873560</url>
  </required_header>
  <id_info>
    <org_study_id>IB-2-1306-020</org_study_id>
    <nct_id>NCT01873560</nct_id>
  </id_info>
  <brief_title>Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention</brief_title>
  <acronym>PERSPECTIVE</acronym>
  <official_title>Influence of Fractional Flow Reserve (FFR) on the Clinical OutcomEs of PERcutaneouS Coronary Intervention (PCI): A ProspECTIVE, Multicenter FFR Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ulsan University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Busan Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sejong General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tokyo Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gifu Heart Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Japanese Red Cross Kyoto Daini Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fractional flow reserve (FFR) is a physiologic index for the determination of&#xD;
      ischemia-causing coronary stenosis as well as drug eluting stent (DES) optimization, even&#xD;
      multiple anatomic imaging parameters have been widely used in clinical practice for the&#xD;
      assessment of optimal stent procedure. Prognostic value of post-stent FFR (FFRpost) have been&#xD;
      rarely evaluated in patient treated with 2nd generation DES. This multicentre, prospective&#xD;
      registry was aimed to evaluate the influence of physiologic parameters on the clinical&#xD;
      outcome after 2nd generation DES implantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who diagnosed obstructive coronary artery disease and treated by DES with FFR&#xD;
      examination would be enrolled, consecutively. FFR measurement would be required at the&#xD;
      baseline and at the end of index PCI procedure. PCI procedure would be performed upon local&#xD;
      routine. Any available 2nd generation DES could be used. Informed consent should be obtained&#xD;
      and protocol should be approved by each collaborator's institutional review board (IRB).&#xD;
      Web-based electronic-case record form (CRF) system will be used for collecting data. All data&#xD;
      will be handled and analyzed by blind fashion at independent core lab. Patient will be&#xD;
      followed-up at each collaborator's hospital at least 2 year after index procedure. Any&#xD;
      adverse event will be reported and addressed immediately by appropriate medical treatment to&#xD;
      protect patient.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Target-vessel failure</measure>
    <time_frame>2 years after index procedure</time_frame>
    <description>During two-year follow-up period, target-vessel failure (composite of cardiac death, target-vessel related myocardial infarction, and clinically-driven target vessel revascularization) will be evaluated. Target vessel will be defined as the treated vessel with DES which assessed by post-stent FFR.&#xD;
All clinical outcome will be reported according to the location of target vessel (LAD vs. non-LAD).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical, angiographic and physiologic predictors for target-vessel failure</measure>
    <time_frame>2 years after index procedure</time_frame>
    <description>Clinical, angiographic and physiologic predictors for target-vessel failure by univariate and multivariate analysis will be performed.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Intravascular ultrasound (IVUS) derived predictors for post-stent FFR and target vessel failure</measure>
    <time_frame>2 years after index procedure</time_frame>
    <description>In patient who performed IVUS examination, IVUS derived parameters will be evaluated for the prediction of post-stent FFR and target-vessel failure</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1250</enrollment>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>FFRpost</arm_group_label>
    <description>High FFRpost group and low FFRpost group were defined according to the optimal cut-off value for predicting clinical outcome.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who diagnosed obstructive coronary artery disease and treated by DES with FFR&#xD;
        examination at the index procedure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  any patient meets eligible criteria who underwent PCI with DES followed by FFR&#xD;
             measurement at the index procedure&#xD;
&#xD;
          -  patient who provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  culprit vessel of acute coronary syndrome&#xD;
&#xD;
          -  failed achieving TIMI 3 flow at the end of PCI&#xD;
&#xD;
          -  left ventricular ejection fraction &lt;30%&#xD;
&#xD;
          -  graft vessel&#xD;
&#xD;
          -  collateral feeder&#xD;
&#xD;
          -  in-stent stenosis&#xD;
&#xD;
          -  primary myocardial or valvular heart disease&#xD;
&#xD;
          -  in patient whose life expectancy less than 2 years&#xD;
&#xD;
          -  visible thrombus of target vessel segment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joon Hyung Doh, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje Univesity Ilsan Paik Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bon-Kwon Koo</last_name>
    <role>Study Director</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inje University Ilsan Paik Hospital</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi</state>
        <zip>411-706</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keimyung University Dongsan Medical Center</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Pijls NH, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Escaned J, Tsurumi Y, Akasaka T, Samady H, De Bruyne B; Fractional Flow Reserve (FFR) Post-Stent Registry Investigators. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002 Jun 25;105(25):2950-4.</citation>
    <PMID>12081986</PMID>
  </reference>
  <reference>
    <citation>Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstr√∏m T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009 Jan 15;360(3):213-24. doi: 10.1056/NEJMoa0807611.</citation>
    <PMID>19144937</PMID>
  </reference>
  <reference>
    <citation>Nam CW, Hur SH, Cho YK, Park HS, Yoon HJ, Kim H, Chung IS, Kim YN, Kim KB, Doh JH, Koo BK, Tahk SJ, Fearon WF. Relation of fractional flow reserve after drug-eluting stent implantation to one-year outcomes. Am J Cardiol. 2011 Jun 15;107(12):1763-7. doi: 10.1016/j.amjcard.2011.02.329. Epub 2011 Apr 8.</citation>
    <PMID>21481828</PMID>
  </reference>
  <reference>
    <citation>Samady H, McDaniel M, Veledar E, De Bruyne B, Pijls NH, Fearon WF, Vaccarino V. Baseline fractional flow reserve and stent diameter predict optimal post-stent fractional flow reserve and major adverse cardiac events after bare-metal stent deployment. JACC Cardiovasc Interv. 2009 Apr;2(4):357-63. doi: 10.1016/j.jcin.2009.01.008.</citation>
    <PMID>19463450</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>June 6, 2013</study_first_submitted>
  <study_first_submitted_qc>June 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2013</study_first_posted>
  <last_update_submitted>March 2, 2019</last_update_submitted>
  <last_update_submitted_qc>March 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Joon Hyung Doh</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>fractional flow reserve</keyword>
  <keyword>drug eluting stent</keyword>
  <keyword>coronary atherosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

